Project Details
Abstract
The Chang Gung Memorial Hospital (CGMH) is hosting a cutting edge new proton
therapy facility which will begin to treat patients in 2013. A few other hospitals in Taiwan
are also planning to import and construct proton facilities for clinical applications.
Comparing to photon therapy, proton therapy beams have excellent physical properties of
delivering higher dose to the tumor and lower doses to surrounding normal tissues. Radiation
doses to the critical organs right behind the Bragg peak are essentially zero so that healthy
tissues can be totally protected. As a result, the tumor control probability (TCP) is increased,
the normal tissue complication probability (NTCP) is reduced, and the occurrence of
secondary cancers is minimized.
Quality assurance (QA) is very important in proton therapy. The QA includes
pre-treatment phantom dose measurements, treatment-planning CT dose simulations, and
on-treatment in vivo dose verifications. In the Bragg peak region where tumor is located, the
dosimetry QA is rather difficult since proton energy is rapidly degraded, dose gradient is
sufficiently large, and relative biological effectiveness (RBE) is increased at the distal edge.
Because of these, ultra-thin dosimeters, Monte Carlo simulations, and microdisimetry
methods are needed for the dose measurements, dose calculations, and RBE determinations.
It is recommended in International Commission on Radiation Units and Measurements
(ICRU) Report 78 that RBE-weighted absorbed doses should be recorded and reported in
proton therapy, especially around the spread-out Bragg peak (SOBP) region.
In this project, we propose to study the in vivo dosimetry for proton therapy by applying
the following techniques: (1) measurements of absorbed doses using calibrated ionization
chambers to establish dose standards for comparisons, (2) studies of characteristic properties
of metal oxide semiconductor field effect transistors (MOSFETs) for in vivo dose
verifications, (3) measurements of microdosimetric lineal energies using self-designed mini
tissue-equivalent proportional counters (mini TEPCs) for RBE determinations, (4)
simulations of MOSFETs and the mini TEPCs by the Monte Carlo FLUKA code for
absorbed dose and RBE calculations.
In CGMH, two different techniques are applied to generate SOBP proton beams, i.e. the
wobbling technique and the pencil-beam scanning technique. The advanced pencil-beam
technique produces fine proton beams of unique properties different from broad beams of the
Wobbling technique. Due to the characteristic feature of pencil beam scanning technique, it
requires thorough investigations of in vivo dosimetry. The dosimeters and methodologies to
be studied in this project involve some advancement of newly developed technologies. The
present study is important not only for academic research but also for clinical application.
Results of this study will be provided to hospitals for clinical use in QA and in vivo
dosimetry. Medical physicist training is an integral part of the objectives of this study.
Project IDs
Project ID:PC10207-0438
External Project ID:NSC102-2314-B182-048
External Project ID:NSC102-2314-B182-048
Status | Finished |
---|---|
Effective start/end date | 01/08/13 → 31/07/14 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.